Primecap Management CO Astrazeneca PLC Transaction History
Primecap Management CO
- $134 Billion
- Q3 2024
A detailed history of Primecap Management CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Primecap Management CO holds 41,980,045 shares of AZN stock, worth $2.81 Billion. This represents 2.45% of its overall portfolio holdings.
Number of Shares
41,980,045
Previous 42,597,235
1.45%
Holding current value
$2.81 Billion
Previous $3.32 Billion
1.54%
% of portfolio
2.45%
Previous 2.44%
Shares
29 transactions
Others Institutions Holding AZN
# of Institutions
1,360Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.22 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL15MShares$1 Billion1.7% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...